Zortress - (0.25,0.5,0.75,1 mg, Tablet, Oral)

Generic Name	Everolimus	Innovator	Novartis
Dosage	0.25,0.5,0.75,1 mg, Tablet, Oral	Branded US Sales	Less Than $1000 mn
Probable FTF	Less Than 5	Known Para IV Filers	Less Than 5
Other ANDA developers	More Than 5	Tentative Approvals	None
Final Approvals	Less Than 5	Generic Launches	Less Than 5
Indication	Used to prevent organ rejection after a kidney or liver transplant
Complexities	Yes

Executive Summary

Patent Status

Launch Timelines and Competition

Company	FTF Status / 180 days exclusivity	30-Months stay	Current Litigation Status	Current Approval Status	Likelihood of launch
************	*** \ **	*** **, ****	*******	********	******** ** *** **, ****
******	*** \ **	***** **, ****	*******	****	****** **** ********
******** ******	*** \ **	***** **, ****	*******	********	******** ** ***** **, ****

Chronology Of Events